세계의 이식 진단 시장 - 규모, 점유율, 동향 분석 : 검사별, 제품별, 용도별, 이식 부위별, 최종 용도별, 지역별, 부문별 예측(2024-2030년)

Transplant Diagnostics Market Size, Share & Trends Analysis Report By Test (Molecular Assays, Non-Molecular Assays), By Product, By Application, By Transplant Area, By End Use, By Region, And Segment Forecasts, 2024 - 2030

US $ 5,950 ￦ 8,302,000

Unprintable PDF & Excel (Single User License)

보고서 PDF 및 엑셀을 1인만 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 불가능합니다.

US $ 6,950 ￦ 9,698,000

Printable PDF & Excel (5-User License)

보고서 PDF 및 엑셀을 동일 기업 내 동일 부서에서 최대 5명까지 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다.

US $ 8,950 ￦ 12,488,000

Printable PDF & Excel (Enterprise License)

보고서 구매 기업 및 그 자회사, 관계사가 사용할 수 있는 라이선스이며, PDF 및 엑셀 텍스트 등의 복사 및 붙여넣기, 인쇄가 가능합니다.

한글목차

이식 진단 시장의 성장과 동향 :

Grand View Research, Inc.의 최신 보고서에 따르면 세계 이식 진단 시장 규모는 2024-2030년에 CAGR 7.3%를 기록했으며, 2030년에는 97억 4,000만 달러에 달할 것으로 예측되고 있습니다. 장기 부전을 자주 일으키는 만성 질환으로 고통받는 환자 증가로 이식 수술에 대한 수요가 급증하고 있습니다. 게다가 줄기세포 치료와 맞춤형 의료의 채용이 확대되고 있어 이식 진단 수요에 영향을 주고 있습니다.

장기 이식과 관련된 위험과 복잡성으로 인해 향상된 고급 진단 도구가 필요합니다. 차세대 시퀀싱(NGS) 기술은 정확도를 높이는 고처리량 진단 도구에 대한 수요가 증가함에 따라 인간 백혈구 항원(HLA) 타이핑에 채택된 혈청학적 기법과 같은 기존의 진단 기법에 빠르게 대체하고 있습니다.

시장의 성장은 세계 일부 지역의 상환 논쟁과 윤리적 문제와 같은 요인에 의해 억제될 것으로 예상됩니다. 또한 중합효소 연쇄반응(PCR)과 NGS장치를 이용한 HLA 매칭을 실시하는 비용이 높다는 것은 신흥국에서의 이식 진단 시장의 성장에 영향을 미치고 있습니다.

이식 진단 시장 보고서 하이라이트

• 시퀀싱 기반 타이핑 부문은 2024-2030년 큰 성장이 예상됩니다. NGS의 높은 채용률은 부문 성장의 주요 요인입니다.
• 북미는 2023년 최대의 수익 점유율을 획득하여 확립된 연구 인프라, 헬스케어 지출 증가, 첨단 진단 기술의 높은 채용, 연구개발 활동의 활성화로 예측기간을 통해 우위를 유지할 것으로 예측됩니다.
• 아시아태평양은 연구 기회 확대, 의료 지출, 의료 관광 산업 및 장기 제공에 대한 의식으로 예측 기간 동안 큰 성장이 예상됩니다.

목차

제1장 조사 방법과 범위

제2장 주요 요약

제3장 이식 진단 시장의 변수, 동향, 범위

• 시장의 소개/계통 전망
• 시장 규모와 성장 전망
• 시장 역학
  • 시장 성장 촉진요인 분석
  • 시장 성장 억제요인 분석
• 이식 진단 시장의 분석 툴
  • Porter's Five Forces 분석
  • PESTEL 분석

제4장 이식 진단 시장 :검사의 추정·동향 분석

• 부문 대시보드
• 이식 진단 시장 :검사의 분석(2023년·2030년)
• 분자 분석
• 시퀀싱 기반 분자 분석
• 비분자 분석

제5장 이식 진단 시장 : 제품의 추정·동향 분석

• 부문 대시보드
• 이식 진단 시장 : 제품의 분석(2023년·2030년)
• 시약 및 소모품
• 기기
• 소프트웨어 및 서비스

제6장 이식 진단 시장 : 용도의 추정·동향 분석

• 부문 대시보드
• 이식 진단 시장 : 용도의 분석(2023년·2030년)
• 진단 용도
  • 감염증 검사
  • 조직 적합성 검사
  • 혈액 프로파일링
• 연구 용도

제7장 이식 진단 시장 : 이식 부위의 추정·동향 분석

• 부문 대시보드
• 이식 진단 시장 : 이식 부위의 분석(2023년·2030년)
• 고형 장기 이식
• 줄기세포 이식
• 연부 조직 이식
• 골수 이식

제8장 이식 진단 시장 : 최종 용도의 추정·동향 분석

• 부문 대시보드
• 이식 진단 시장 : 최종 용도의 분석(2023년·2030년)
• 병원·이식 센터
• 연구 및 학술기관
• 독립 기준 실험실

제9장 이식 진단 시장 :지역의 추정·동향 분석

• 이식 진단 시장 점유율 : 지역별(2023년·2030년)
• 북미
  • 미국
  • 캐나다
  • 멕시코
• 유럽
  • 영국
  • 독일
  • 프랑스
  • 이탈리아
  • 스페인
  • 덴마크
  • 스웨덴
  • 노르웨이
• 아시아태평양
  • 일본
  • 중국
  • 인도
  • 호주
  • 한국
  • 태국
• 라틴아메리카
  • 브라질
  • 아르헨티나
• 중동 및 아프리카
  • 남아프리카
  • 사우디아라비아
  • 아랍에미리트(UAE)
  • 쿠웨이트

제10장 경쟁 구도

• 주요 시장 진출기업에 의한 최근의 동향과 영향 분석
• 기업 분류
• 기업 히트맵 분석
• 기업 프로파일
  • Thermo Fisher Scientific, Inc.
  • Illumina, Inc.
  • F. Hoffmann La-Roche Ltd
  • Abbott
  • QIAGEN
  • Bruker
  • BD(Becton, Dickinson and Company)
  • Werfen(Immucor, Inc.)
  • Bio-Rad Laboratories, Inc.
  • Omixon Inc.

JHS

영문 목차

영문목차

Transplant Diagnostics Market Growth & Trends:

The global transplant diagnostics market size is expected to reach USD 9.74 billion by 2030, registering a CAGR of 7.3% from 2024 to 2030, according to a new report by Grand View Research, Inc. An increasing number of patients suffering from chronic diseases frequently leading to organ failure is creating an upsurge in demand for transplant procedures. In addition, the adoption of stem cell therapy and personalized medicine is escalating, thereby influencing demand for transplant diagnostics.

Risks and complexities associated with organ transplants necessitate the need for improved and sophisticated diagnostic tools. Next-Generation Sequencing (NGS) technology is rapidly replacing traditional diagnostic methods, such as serological techniques employed in Human Leukocyte Antigen (HLA) typing, owing to the growing demand for high-throughput diagnostic tools with enhanced accuracy.

Market growth is expected to be restrained by factors such as reimbursement controversies and ethical issues in some parts of the world. In addition, the high cost of performing HLA matching using Polymerase Chain Reaction (PCR) and NGS devices is challenging the growth of the transplant diagnostics market in developing countries.

Transplant Diagnostics Market Report Highlights:

• The sequencing-based typing segment is anticipated to witness significant growth from 2024 to 2030. High adoption of NGS is a major factor driving segment growth
• North America captured the largest revenue share in 2023 and is expected to maintain its dominance throughout the forecast period due to well-established research infrastructure, increasing healthcare expenditure, high adoption of advanced diagnostic techniques, and growing R&D activities
• Asia Pacific is expected to witness significant growth during the forecast period owing to expanding research opportunities, healthcare expenditure, the medical tourism industry, and awareness regarding organ donation

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
• 1.2. Market Definitions
• 1.3. Research Methodology
  • 1.3.1. Information Procurement
  • 1.3.2. Information or Data Analysis
  • 1.3.3. Market Formulation & Data Visualization
  • 1.3.4. Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1. List of Data Sources

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
• 2.3. Competitive Insights

Chapter 3. Transplant Diagnostics Market Variables, Trends, & Scope

• 3.1. Market Introduction/Lineage Outlook
• 3.2. Market Size and Growth Prospects (USD Million)
• 3.3. Market Dynamics
  • 3.3.1. Market Drivers Analysis
  • 3.3.2. Market Restraints Analysis
• 3.4. Transplant Diagnostics Market Analysis Tools
  • 3.4.1. Porter's Analysis
    • 3.4.1.1. Bargaining power of the suppliers
    • 3.4.1.2. Bargaining power of the buyers
    • 3.4.1.3. Threats of substitution
    • 3.4.1.4. Threats from new entrants
    • 3.4.1.5. Competitive rivalry
  • 3.4.2. PESTEL Analysis
    • 3.4.2.1. Political landscape
    • 3.4.2.2. Economic and Social landscape
    • 3.4.2.3. Technological landscape
    • 3.4.2.4. Environmental landscape
    • 3.4.2.5. Legal landscape

Chapter 4. Transplant Diagnostics Market: Test Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. Transplant Diagnostics: Test Outlook Analysis, USD Million, 2023 & 2030
• 4.3. Molecular Assays
  • 4.3.1. PCR-based Molecular Assays
    • 4.3.1.1. PCR-based Molecular Assays Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.3.2. Real-Time PCR
    • 4.3.2.1. Real-Time PCR Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.3.3. Sequence-based Primer-PCR
    • 4.3.3.1. Sequence-based Primer-PCR Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.3.4. Sequence-specific Oligonucleotide-PCR
    • 4.3.4.1. Sequence-specific Oligonucleotide-PCR Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.3.5. Other PCR-based Molecular Assays
    • 4.3.5.1. Other PCR-based Molecular Assays Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.4. Sequencing-based Molecular Assays
  • 4.4.1. Sanger Sequencing
    • 4.4.1.1. Sanger Sequencing Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.4.2. Next Generation Sequencing
    • 4.4.2.1. Next Generation Sequencing Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.4.3. Other Sequencing-based Molecular Assays
    • 4.4.3.1. Other Sequencing-based Molecular Assays Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.5. Non-molecular Assays
  • 4.5.1. Serological Assays Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.5.1.1. Serological Assays Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.5.2. Mixed Lymphocyte Culture Assays Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.5.2.1. Mixed Lymphocyte Culture Assays Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Transplant Diagnostics Market: Product Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. Transplant Diagnostics Market: Product Analysis, USD Million, 2023 & 2030
• 5.3. Reagents & Consumables
  • 5.3.1. Reagents & Consumables Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.4. Instruments
  • 5.4.1. Instruments Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.5. Software and Services
  • 5.5.1. Software and Services Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Transplant Diagnostics Market: Application Estimates & Trend Analysis

• 6.1. Segment Dashboard
• 6.2. Transplant Diagnostics Market: Application Analysis, USD Million, 2023 & 2030
• 6.3. Diagnostics Application
  • 6.3.1. Diagnostics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.3.2. Infectious Disease Testing
    • 6.3.2.1. Infectious Disease Testing Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.3.3. Histocompatibility Testing
    • 6.3.3.1. Histocompatibility Testing Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.3.4. Blood Profiling
    • 6.3.4.1. Blood Profiling Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.4. Research Application
  • 6.4.1. Research Application Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Transplant Diagnostics Market: Transplant Area Estimates & Trend Analysis

• 7.1. Segment Dashboard
• 7.2. Transplant Diagnostics Market: Transplant Area Analysis, USD Million, 2023 & 2030
• 7.3. Solid Organ Transplantation
  • 7.3.1. Kidney Transplantation
    • 7.3.1.1. Kidney Transplantation Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.3.2. Liver Transplantation
    • 7.3.2.1. Liver Transplantation Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.3.3. Heart Transplantation
    • 7.3.3.1. Heart Transplantation Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.3.4. Lungs Transplantation
    • 7.3.4.1. Lungs Transplantation Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.3.5. Pancreas Transplantation
    • 7.3.5.1. Pancreas Transplantation Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.3.6. Other Organs Transplantation
    • 7.3.6.1. Other Organs Transplantation Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 7.4. Stem Cell Transplantation
  • 7.4.1. Stem Cell Transplantation Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 7.5. Soft Tissue Transplantation
  • 7.5.1. Soft Tissue Transplantation Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 7.6. Bone Marrow Transplantation
  • 7.6.1. Bone Marrow Transplantation Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Transplant Diagnostics Market: End Use Estimates & Trend Analysis

• 8.1. Segment Dashboard
• 8.2. Transplant Diagnostics Market: End Use Analysis, USD Million, 2023 & 2030
• 8.3. Hospitals and Transplant Centers
  • 8.3.1. Hospitals and Transplant Centers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 8.4. Research and Academic Institutes
  • 8.4.1. Research and Academic Institutes Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 8.5. Independent Reference Laboratories
  • 8.5.1. Independent Reference Laboratories Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 9. Transplant Diagnostics Market: Regional Estimates & Trend Analysis

• 9.1. Transplant Diagnostics Market Share, By Region, 2023 & 2030, USD Million
• 9.2. North America
  • 9.2.1. North America Transplant Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 9.2.2. U.S.
    • 9.2.2.1. U.S. Transplant Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 9.2.3. Canada
    • 9.2.3.1. Canada Transplant Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 9.2.4. Mexico
    • 9.2.4.1. Mexico Transplant Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 9.3. Europe
  • 9.3.1. Europe Transplant Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 9.3.2. U.K.
    • 9.3.2.1. U.K. Transplant Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 9.3.3. Germany
    • 9.3.3.1. Germany Transplant Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 9.3.4. France
    • 9.3.4.1. France Transplant Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 9.3.5. Italy
    • 9.3.5.1. Italy Transplant Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 9.3.6. Spain
    • 9.3.6.1. Spain Transplant Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 9.3.7. Denmark
    • 9.3.7.1. Denmark Transplant Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 9.3.8. Sweden
    • 9.3.8.1. Sweden Transplant Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 9.3.9. Norway
    • 9.3.9.1. Norway Transplant Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 9.4. Asia Pacific
  • 9.4.1. Asia Pacific Transplant Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 9.4.2. Japan
    • 9.4.2.1. Japan Transplant Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 9.4.3. China
    • 9.4.3.1. China Transplant Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 9.4.4. India
    • 9.4.4.1. India Transplant Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 9.4.5. Australia
    • 9.4.5.1. Australia Transplant Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 9.4.6. South Korea
    • 9.4.6.1. South Korea Transplant Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 9.4.7. Thailand
    • 9.4.7.1. Thailand Transplant Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 9.5. Latin America
  • 9.5.1. Latin America Transplant Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 9.5.2. Brazil
    • 9.5.2.1. Brazil Transplant Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 9.5.3. Argentina
    • 9.5.3.1. Argentina Transplant Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 9.6. Middle East and Africa
  • 9.6.1. Middle East and Africa Transplant Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 9.6.2. South Africa
    • 9.6.2.1. South Africa Transplant Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 9.6.3. Saudi Arabia
    • 9.6.3.1. Saudi Arabia Transplant Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 9.6.4. UAE
    • 9.6.4.1. UAE Transplant Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 9.6.5. Kuwait
    • 9.6.5.1. Kuwait Transplant Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 10. Competitive Landscape

• 10.1. Recent Developments & Impact Analysis by Key Market Participants
• 10.2. Company Categorization
• 10.3. Company Heat Map Analysis
• 10.4. Company Profiles
  • 10.4.1. Thermo Fisher Scientific, Inc.
    • 10.4.1.1. Participant's Overview
    • 10.4.1.2. Financial Performance
    • 10.4.1.3. Product Benchmarking
    • 10.4.1.4. Recent Developments/ Strategic Initiatives
  • 10.4.2. Illumina, Inc.
    • 10.4.2.1. Participant's Overview
    • 10.4.2.2. Financial Performance
    • 10.4.2.3. Product Benchmarking
    • 10.4.2.4. Recent Developments/ Strategic Initiatives
  • 10.4.3. F. Hoffmann La-Roche Ltd
    • 10.4.3.1. Participant's Overview
    • 10.4.3.2. Financial Performance
    • 10.4.3.3. Product Benchmarking
    • 10.4.3.4. Recent Developments/ Strategic Initiatives
  • 10.4.4. Abbott
    • 10.4.4.1. Participant's Overview
    • 10.4.4.2. Financial Performance
    • 10.4.4.3. Product Benchmarking
    • 10.4.4.4. Recent Developments/ Strategic Initiatives
  • 10.4.5. QIAGEN
    • 10.4.5.1. Participant's Overview
    • 10.4.5.2. Financial Performance
    • 10.4.5.3. Product Benchmarking
    • 10.4.5.4. Recent Developments/ Strategic Initiatives
  • 10.4.6. Bruker
    • 10.4.6.1. Participant's Overview
    • 10.4.6.2. Financial Performance
    • 10.4.6.3. Product Benchmarking
    • 10.4.6.4. Recent Developments/ Strategic Initiatives
  • 10.4.7. BD (Becton, Dickinson and Company)
    • 10.4.7.1. Participant's Overview
    • 10.4.7.2. Financial Performance
    • 10.4.7.3. Product Benchmarking
    • 10.4.7.4. Recent Developments/ Strategic Initiatives
  • 10.4.8. Werfen (Immucor, Inc.)
    • 10.4.8.1. Participant's Overview
    • 10.4.8.2. Financial Performance
    • 10.4.8.3. Product Benchmarking
    • 10.4.8.4. Recent Developments/ Strategic Initiatives
  • 10.4.9. Bio-Rad Laboratories, Inc.
    • 10.4.9.1. Participant's Overview
    • 10.4.9.2. Financial Performance
    • 10.4.9.3. Product Benchmarking
    • 10.4.9.4. Recent Developments/ Strategic Initiatives
  • 10.4.10. Omixon Inc.
    • 10.4.10.1. Participant's Overview
    • 10.4.10.2. Financial Performance
    • 10.4.10.3. Product Benchmarking
    • 10.4.10.4. Recent Developments/ Strategic Initiatives

관련자료